Literature DB >> 2434067

Clinical characteristics of choroidal neovascular membranes.

N M Bressler, S B Bressler, E S Gragoudas.   

Abstract

Eighty-three choroidal neovascular membranes (CNVMs) associated with pathologic entities other than age-related macular degeneration (study group) were compared with 64 CNVMs associated with macular degeneration (comparison group). Nine CNVMs (11%) in the study group, compared with 28 CNVMs (44%) in the comparison group, were occult membranes. Of the remaining well-defined CNVMs, 16 (22%) in the study group, compared with 21 (58%) in the comparison group, were subfoveal. Of the well-defined subfoveal membranes, four (25%) in the study group, compared with 17 (81%) in the control group, were large (greater than 1500 micron in size). All large subfoveal membranes occurred in patients over 55 years of age. Thus, in this study the majority of CNVMs associated with pathologic entities other than age-related macular degeneration were well defined and not subfoveal at initial presentation. The majority of CNVMs associated with macular degeneration were occult or subfoveal. Membranes in patients over 55 years of age, regardless of cause, were commonly found to be occult or subfoveal at presentation.

Entities:  

Mesh:

Year:  1987        PMID: 2434067     DOI: 10.1001/archopht.1987.01060020063030

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  24 in total

Review 1.  Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.

Authors:  G Soubrane; N M Bressler
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Age related macular degeneration. New hope for a common problem comes from photodynamic therapy.

Authors:  N M Bressler
Journal:  BMJ       Date:  2000-12-09

3.  Electrophysiological changes after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age related macular degeneration.

Authors:  C Lüke; S Aisenbrey; M Lüke; G Marzella; K U Bartz-Schmidt; P Walter
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

4.  Electro-oculographic findings after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age-related macular degeneration.

Authors:  Christoph Lüke; Nils Alteheld; Sabine Aisenbrey; Matthias Lüke; Karl Ulrich Bartz-Schmidt; Peter Walter; Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-23       Impact factor: 3.117

5.  Indirect photocoagulation of subfoveal choroidal neovascularization in age-related macular degeneration.

Authors:  L V Angioletti; P J Colquhoun; A D Kulik; E H Malpica
Journal:  Bull N Y Acad Med       Date:  1991 Jul-Aug

6.  Submacular scar excision in age-related macular degeneration.

Authors:  K J Blinder; G A Peyman; C L Paris; C M Gremillion
Journal:  Int Ophthalmol       Date:  1991-07       Impact factor: 2.031

7.  Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.

Authors:  J N Kirkpatrick; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

8.  Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.

Authors:  M C Gillies; J P Sarks; P E Beaumont; A B Hunyor; D McKay; M Kearns; P J McClusky; S H Sarks
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

9.  Correlation between Octopus perimetry and fluorescein angiography after strontium-90 plaque brachytherapy for subfoveal exudative age related macular degeneration.

Authors:  A Jaakkola; E Vesti; I Immonen
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

10.  Asymmetry of disciform scarring in bilateral disease when one eye is treated with radiotherapy.

Authors:  P M Hart; D B Archer; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.